Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users
Background: Statin use may exacerbate exercise-induced skeletal muscle injury caused by reduced coenzyme Q10 (CoQ10) levels, which are postulated to produce mitochondrial dysfunction. Objectives: We determined the effect of prolonged moderate-intensity exercise on markers of muscle injury in statin users with and without statin-associated muscle symptoms. We also examined the association between leukocyte CoQ10 levels and muscle markers, muscle performance, and reported muscle symptoms. Methods: Symptomatic (n = 35; age 62 ± 7 years) and asymptomatic statin users (n = 34; age 66 ± 7 years) and control subjects (n = 31; age 66 ± 5 years) walked 30, 40, or 50 km/d for 4 consecutive days. Muscle injury markers (lactate dehydrogenase, creatine kinase, myoglobin, cardiac troponin I, and N-terminal pro-brain natriuretic peptide), muscle performance, and reported muscle symptoms were assessed at baseline and after exercise. Leukocyte CoQ10 was measured at baseline. Results: All muscle injury markers were comparable at baseline (P > 0.05) and increased following exercise (P < 0.001), with no differences in the magnitude of exercise-induced elevations among groups (P > 0.05). Muscle pain scores were higher at baseline in symptomatic statin users (P < 0.001) and increased similarly in all groups following exercise (P < 0.001). Muscle relaxation time increased more in symptomatic statin users than in control subjects following exercise (P = 0.035). CoQ10 levels did not differ among symptomatic (2.3 nmol/U; IQR: 1.8-2.9 nmol/U), asymptomatic statin users (2.1 nmol/U; IQR: 1.8-2.5 nmol/U), and control subjects (2.1 nmol/U; IQR: 1.8-2.3 nmol/U; P = 0.20), and did not relate to muscle injury markers, fatigue resistance, or reported muscle symptoms. Conclusions: Statin use and the presence of statin-associated muscle symptoms does not exacerbate exercise-induced muscle injury after moderate exercise. Muscle injury markers were not related to leukocyte CoQ10 levels.
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article/Letter to editor biblioteca |
Language: | English |
Subjects: | coenzyme Q10, moderate-intensity exercise, muscle injury, muscle performance, statin-associated muscle symptoms, |
Online Access: | https://research.wur.nl/en/publications/prolonged-moderate-intensity-exercise-does-not-increase-muscle-in |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
dig-wur-nl-wurpubs-613274 |
---|---|
record_format |
koha |
spelling |
dig-wur-nl-wurpubs-6132742024-12-04 Allard, Neeltje A.E. Janssen, Lando Lagerwaard, Bart Nuijten, Malou A.H. Bongers, Coen C.W.G. Rodenburg, Richard J. Thompson, Paul D. Eijsvogels, Thijs M.H. Assendelft, Willem J.J. Schirris, Tom J.J. Timmers, Silvie Hopman, Maria T.E. Article/Letter to editor Journal of the American College of Cardiology 81 (2023) 14 ISSN: 0735-1097 Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users 2023 Background: Statin use may exacerbate exercise-induced skeletal muscle injury caused by reduced coenzyme Q10 (CoQ10) levels, which are postulated to produce mitochondrial dysfunction. Objectives: We determined the effect of prolonged moderate-intensity exercise on markers of muscle injury in statin users with and without statin-associated muscle symptoms. We also examined the association between leukocyte CoQ10 levels and muscle markers, muscle performance, and reported muscle symptoms. Methods: Symptomatic (n = 35; age 62 ± 7 years) and asymptomatic statin users (n = 34; age 66 ± 7 years) and control subjects (n = 31; age 66 ± 5 years) walked 30, 40, or 50 km/d for 4 consecutive days. Muscle injury markers (lactate dehydrogenase, creatine kinase, myoglobin, cardiac troponin I, and N-terminal pro-brain natriuretic peptide), muscle performance, and reported muscle symptoms were assessed at baseline and after exercise. Leukocyte CoQ10 was measured at baseline. Results: All muscle injury markers were comparable at baseline (P > 0.05) and increased following exercise (P < 0.001), with no differences in the magnitude of exercise-induced elevations among groups (P > 0.05). Muscle pain scores were higher at baseline in symptomatic statin users (P < 0.001) and increased similarly in all groups following exercise (P < 0.001). Muscle relaxation time increased more in symptomatic statin users than in control subjects following exercise (P = 0.035). CoQ10 levels did not differ among symptomatic (2.3 nmol/U; IQR: 1.8-2.9 nmol/U), asymptomatic statin users (2.1 nmol/U; IQR: 1.8-2.5 nmol/U), and control subjects (2.1 nmol/U; IQR: 1.8-2.3 nmol/U; P = 0.20), and did not relate to muscle injury markers, fatigue resistance, or reported muscle symptoms. Conclusions: Statin use and the presence of statin-associated muscle symptoms does not exacerbate exercise-induced muscle injury after moderate exercise. Muscle injury markers were not related to leukocyte CoQ10 levels. en application/pdf https://research.wur.nl/en/publications/prolonged-moderate-intensity-exercise-does-not-increase-muscle-in 10.1016/j.jacc.2023.01.043 https://edepot.wur.nl/628734 coenzyme Q10 moderate-intensity exercise muscle injury muscle performance statin-associated muscle symptoms Wageningen University & Research |
institution |
WUR NL |
collection |
DSpace |
country |
Países bajos |
countrycode |
NL |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-wur-nl |
tag |
biblioteca |
region |
Europa del Oeste |
libraryname |
WUR Library Netherlands |
language |
English |
topic |
coenzyme Q10 moderate-intensity exercise muscle injury muscle performance statin-associated muscle symptoms coenzyme Q10 moderate-intensity exercise muscle injury muscle performance statin-associated muscle symptoms |
spellingShingle |
coenzyme Q10 moderate-intensity exercise muscle injury muscle performance statin-associated muscle symptoms coenzyme Q10 moderate-intensity exercise muscle injury muscle performance statin-associated muscle symptoms Allard, Neeltje A.E. Janssen, Lando Lagerwaard, Bart Nuijten, Malou A.H. Bongers, Coen C.W.G. Rodenburg, Richard J. Thompson, Paul D. Eijsvogels, Thijs M.H. Assendelft, Willem J.J. Schirris, Tom J.J. Timmers, Silvie Hopman, Maria T.E. Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users |
description |
Background: Statin use may exacerbate exercise-induced skeletal muscle injury caused by reduced coenzyme Q10 (CoQ10) levels, which are postulated to produce mitochondrial dysfunction. Objectives: We determined the effect of prolonged moderate-intensity exercise on markers of muscle injury in statin users with and without statin-associated muscle symptoms. We also examined the association between leukocyte CoQ10 levels and muscle markers, muscle performance, and reported muscle symptoms. Methods: Symptomatic (n = 35; age 62 ± 7 years) and asymptomatic statin users (n = 34; age 66 ± 7 years) and control subjects (n = 31; age 66 ± 5 years) walked 30, 40, or 50 km/d for 4 consecutive days. Muscle injury markers (lactate dehydrogenase, creatine kinase, myoglobin, cardiac troponin I, and N-terminal pro-brain natriuretic peptide), muscle performance, and reported muscle symptoms were assessed at baseline and after exercise. Leukocyte CoQ10 was measured at baseline. Results: All muscle injury markers were comparable at baseline (P > 0.05) and increased following exercise (P < 0.001), with no differences in the magnitude of exercise-induced elevations among groups (P > 0.05). Muscle pain scores were higher at baseline in symptomatic statin users (P < 0.001) and increased similarly in all groups following exercise (P < 0.001). Muscle relaxation time increased more in symptomatic statin users than in control subjects following exercise (P = 0.035). CoQ10 levels did not differ among symptomatic (2.3 nmol/U; IQR: 1.8-2.9 nmol/U), asymptomatic statin users (2.1 nmol/U; IQR: 1.8-2.5 nmol/U), and control subjects (2.1 nmol/U; IQR: 1.8-2.3 nmol/U; P = 0.20), and did not relate to muscle injury markers, fatigue resistance, or reported muscle symptoms. Conclusions: Statin use and the presence of statin-associated muscle symptoms does not exacerbate exercise-induced muscle injury after moderate exercise. Muscle injury markers were not related to leukocyte CoQ10 levels. |
format |
Article/Letter to editor |
topic_facet |
coenzyme Q10 moderate-intensity exercise muscle injury muscle performance statin-associated muscle symptoms |
author |
Allard, Neeltje A.E. Janssen, Lando Lagerwaard, Bart Nuijten, Malou A.H. Bongers, Coen C.W.G. Rodenburg, Richard J. Thompson, Paul D. Eijsvogels, Thijs M.H. Assendelft, Willem J.J. Schirris, Tom J.J. Timmers, Silvie Hopman, Maria T.E. |
author_facet |
Allard, Neeltje A.E. Janssen, Lando Lagerwaard, Bart Nuijten, Malou A.H. Bongers, Coen C.W.G. Rodenburg, Richard J. Thompson, Paul D. Eijsvogels, Thijs M.H. Assendelft, Willem J.J. Schirris, Tom J.J. Timmers, Silvie Hopman, Maria T.E. |
author_sort |
Allard, Neeltje A.E. |
title |
Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users |
title_short |
Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users |
title_full |
Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users |
title_fullStr |
Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users |
title_full_unstemmed |
Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users |
title_sort |
prolonged moderate-intensity exercise does not increase muscle injury markers in symptomatic or asymptomatic statin users |
url |
https://research.wur.nl/en/publications/prolonged-moderate-intensity-exercise-does-not-increase-muscle-in |
work_keys_str_mv |
AT allardneeltjeae prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers AT janssenlando prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers AT lagerwaardbart prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers AT nuijtenmalouah prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers AT bongerscoencwg prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers AT rodenburgrichardj prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers AT thompsonpauld prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers AT eijsvogelsthijsmh prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers AT assendelftwillemjj prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers AT schirristomjj prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers AT timmerssilvie prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers AT hopmanmariate prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers |
_version_ |
1819141718254026752 |